29.03.2010 • NewsGlaxoSmithKline (GSK)Japan

Glaxo Seeks Out Japanese Partnerships

GlaxoSmithKline is looking to join up with small and medium-sized companies in Japan to help it develop and distribute new medicines, the Financial Times reported in its Monday edition. Glaxo's Asia-Pacific head Marc Dunoyer said the British drugs firm was looking to work with and invest in firms but would not take a controlling stake.

"The medium-sized segment of Japan is where we're going to focus our attention," Dunoyer was cited as saying in the FT. "It's about reassuring them that we're not going to take them out, but that we have some complementary areas," Dunoyer said.

Glaxo is eyeing new opportunities in Japan, where a raft of medicines that are already well established in home markets are winning approval and being launched. Emerging markets, with nine-month sales of £2.1 billion and year-on-year growth of 19%, currently make up 13% of Glaxo group sales. Japan accounts for some 4%.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.